Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
American Journal of Epidemiology|September 9, 2020
Oral Glucocorticoids and Incident Treatment of Diabetes Mellitus, Hypertension, and Venous Thromboembolism in ChildrenDaniel B Horton, Fenglong Xie, Lang Chen, et al.
The Journal of Rheumatology|August 4, 2012
Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA RegistryTimothy Beukelman, Sarah Ringold, Trevor E Davis, et al.
Clinical Pharmacology and Therapeutics|September 27, 2024
Infrequent Resolution of Vaso-Occlusive Crises in Routine Clinical Care Among Patients Mimicking the Exa-Cel Trial Population: A Cohort Study of Medicaid EnrolleesMufaddal Mahesri, Su Been Lee, Raisa Levin, et al.
RMD Open|May 25, 2023
Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA RegistryColleen K Correll, Scott Stryker, David Collier, et al.
Pediatric Rheumatology Online Journal|September 7, 2016
Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patientsMelissa L Mannion, Fenglong Xie, John Baddley, et al.
Arthritis Care & Research|June 14, 2021
Effectiveness and Safety of High-Dose Biologics in Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research AllianceColleen K Correll, Peter Shrader, Anne Dennos, et al.
Arthritis Care & Research|January 18, 2022
Dosing Variation at Initiation of Adalimumab and Etanercept and Clinical Outcomes in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry StudyRuud H J Verstegen, Peter Shrader, Stephen J Balevic, et al.
Emerging Infectious Diseases|September 6, 2011
Geographic distribution of endemic fungal infections among older persons, United StatesJohn W Baddley, Kevin L Winthrop, Nivedita M Patkar, et al.
Pediatric Rheumatology Online Journal|November 11, 2017
Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective studyMatthew L Stoll, James Aaron Grubbs, Timothy Beukelman, et al.
The Journal of Rheumatology|September 17, 2017
Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after DiagnosisPamela F Weiss, Rui Xiao, Timothy G Brandon, et al.
Pageof 13